Showing results (21-30 of 215) with videos related to
Sort By:
Pageof 22
Journal of Biomolecular Screening|November 19, 2013
Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experienceKelly L Johnston, Louise Ford, Mark J TaylorSymbiosis (Philadelphia, Pa.)|August 24, 2010
The Wolbachia endosymbiont as an anti-filarial nematode targetBarton E Slatko, Mark J Taylor, Jeremy M FosterPlos Pathogens|November 11, 2011
Anti-filarial activity of antibiotic therapy is due to extensive apoptosis after Wolbachia depletion from filarial nematodesFrederic Landmann, Denis Voronin, William Sullivan, et al.Molecular Autism|March 21, 2017
Etiological influences on the stability of autistic traits from childhood to early adulthood: evidence from a twin studyMark J Taylor, Christopher Gillberg, Paul Lichtenstein, et al.Plos Neglected Tropical Diseases|February 25, 2026
The impact of the termination of Lymphatic Filariasis mass drug administration on Soil-transmitted Helminth prevalence in school children in MalawiFaduma Farah, Claudio Fronterrè, Mark J Taylor, et al.Molecular and Biochemical Parasitology|August 4, 2004
Population dynamics of Wolbachia bacterial endosymbionts in Brugia malayiHelen F McGarry, Gillian L Egerton, Mark J TaylorJournal of the American Academy of Child and Adolescent Psychiatry|February 11, 2019
A Twin Study on the Association Between Psychotic Experiences and Tobacco Use During AdolescenceWikus Barkhuizen, Mark J Taylor, Daniel Freeman, et al.Filaria Journal|June 4, 2005
Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathwayHelen F McGarry, Leigh D Plant, Mark J TaylorDrug Discovery Today|November 1, 2005
Quantitative risk modelling for new pharmaceutical compoundsZhengru Tang, Mark J Taylor, Paulo Lisboa, et al.Expert Review of Anti-Infective Therapy|June 3, 2009
Current practices in the management of lymphatic filariasisMoses J Bockarie, Mark J Taylor, John O GyapongPageof 22